ArticleBMC cancer2024

Exosomal miR-6126 as a novel therapeutic target for overcoming resistance of anti-cancer effect in hepatocellular carcinoma.

Hyemin Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.